You are here: Industry Insights > Pain

News List

Effect Sizes Uncertain for Meds Versus Placebo in Knee OA drugs
December 29, 2018
For patients with knee osteoarthritis and at least 12 months of follow-up, there is uncertainty around estimates of effect size for the change in pain in association with medications versus placebo.....
Beckley Canopy Therapeutics raises £7.4m for cannabis R&D pharmaphorum
December 05, 2018
Oxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the treatment of pain and to help tackle opioid addiction.
Spanish authorities restrict prescription of Nolotil after British patient deaths pharmaceutical-technology
November 08, 2018
Spain’s healthcare regulator the Agency of Medicines and Medical Devices (AEMPS) has published a review of popular pain drug Nolotil (metamizole) following rising complications and deaths associated with the side effects of the medications in British pati
The Global Pain Index – an insightful survey worldwide biospectrumasia
October 24, 2018
GSK Consumer Healthcare unveiled the Southeast Asia’s 2017 Global Pain Index (GPI) on 20th June 2017。
Can sugar pills actually relieve chronic pain? europeanpharmaceuticalreview
September 14, 2018
A sugar pill could benefit patients suffering from chronic pain with specific brain anatomy and psychological traits…
Could a chili pepper derivative used for pain also help fight obesity? fiercebiotech
July 20, 2018
Capsaicin is a natural compound that makes chili peppers spicy. Some of its medical benefits have been known for decades, including its potential to help manage pain. Now scientists believe it may also fight obesity.
To treat pain, you need to treat the patient worldpharmanews
May 08, 2018
People in chronic pain are some of the most difficult patients to treat. They have complex circumstances that medicine can't always remedy.
Acute Pain - 2018 Pipeline Highlights biospace
April 20, 2018
Acute Pain Pipeline Highlights - 2018, provides the most up-to-date information on key pipeline products in the global Acute Pain market.
A Review of Abuse-Deterrent Opioids For Chronic Nonmalignant Pain ncbi
November 30, 2017
Chronic nonmalignant pain is a silent epidemic in the U.S. that affects approximately 116 million Americans.
Ibuprofen better choice over oral morphine for pain relief in children europeanpharmaceuticalreview
October 11, 2017
Widely available ibuprofen is a better choice for pain relief in children who have undergone minor surgery, as it has fewer adverse effects compared with oral morphine…

Previous page 1 2 3 4 5 6 Next page